Literature DB >> 19022815

Lessons from multiple sclerosis: models, concepts, observations.

H Wekerle1.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is often termed "the" model of human multiple sclerosis (MS). This is, however, an oversimplification. MS is a multifaceted disorder, with no single experimental model representing the entire complexity of the human disease. On the other hand, EAE comes in numerous, distinct variants, which may reflect individual aspects of MS. This presentation reviews EAE variants and their usability as models for human MS. New transgenic models representing mechanisms determining spontaneous initiation, the course of central nervous system (CNS) autoimmunity, the distribution of lesions within the CNS and the cellular composition of the inflammatory infiltrate are discussed. Aspects of the early, inflammatory phase of MS plaque generation, in particular concerning the dynamics of immune cell invasion into the CNS, are also reviewed. Finally, the usability of EAE models for discovery and validation of MS drugs is discussed.

Entities:  

Mesh:

Year:  2008        PMID: 19022815     DOI: 10.1136/ard.2008.098020

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  36 in total

Review 1.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

Review 2.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

3.  Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis.

Authors:  Oliver W Gramlich; Stephanie C Joachim; Philip F Gottschling; Panagoitis Laspas; Clemens S Cuny; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02-23       Impact factor: 3.117

Review 4.  Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.

Authors:  Nabil K El Ayoubi; Samia J Khoury
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

5.  Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.

Authors:  Wei-Wei Wang; Lin Lu; Tian-Hao Bao; Hong-Miao Zhang; Jing Yuan; Wei Miao; Shu-Fen Wang; Zhi-Cheng Xiao
Journal:  J Mol Neurosci       Date:  2015-10-29       Impact factor: 3.444

6.  MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.

Authors:  Magali Irla; Natalia Küpfer; Tobias Suter; Rami Lissilaa; Mahdia Benkhoucha; Jonathan Skupsky; Patrice H Lalive; Adriano Fontana; Walter Reith; Stéphanie Hugues
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

Review 7.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 8.  Novel approaches for identifying target antigens of autoreactive human B and T cells.

Authors:  Klaus Dornmair; Edgar Meinl; Reinhard Hohlfeld
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

9.  Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.

Authors:  K Mangano; A Nicoletti; F Patti; M Donia; L Malaguarnera; S Signorelli; G Magro; V Muzio; B Greco; P Zaratin; P Meroni; M Zappia; F Nicoletti
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

10.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.